BioProcess360

Abselion specializes in the development of biological sensors aimed at the rapid and cost-effective detection of biological substances such as proteins, DNA, and small molecules. The company focuses on simplifying the analysis of these biomolecules for pharmaceutical research and manufacturing. Its diagnostic analyzers and kits facilitate the analysis of biomolecular interactions, including protein interaction analysis, enabling researchers to achieve sensitive and timely medical diagnoses. Through its innovative technology, Abselion enhances the efficiency of biomedical research and contributes to advancements in medical diagnostics.

IRUBIS GmbH, founded in 2017 and headquartered in Munich, Germany, specializes in the development of advanced mid-infrared (MIR) spectrometers and attenuated total reflection (ATR) crystals. The company integrates semiconductor technology with infrared spectroscopy to create instruments designed for real-time monitoring of bioprocesses, particularly in the pharmaceutical sector. Its offerings include a measurement system that enables online monitoring of glucose and lactate in bioreactors without contamination risk, as well as a range of ATR crystals that enhance the capabilities of Fourier transform infrared (FTIR) spectrometers. IRUBIS aims to set a new standard for online control in bioprocessing through its innovative MIR spectroscopy solutions, facilitating continuous monitoring and control of nutrient concentrations and other critical parameters in laboratory settings.